- A former Biogen employee turned whistleblower, Michael Bawduniak, alleged Biogen paid kickbacks to doctors to encourage them to prescribe its multiple sclerosis drugs.
- Bawduniak will receive about $250 million of the federal proceeds, according to the Justice Department.
- Biogen, in a statement Monday, denied any wrongdoing in the case.
Biogen disclosed in its second quarter report that it had reached an agreement in principle to pay $900 million to resolve the lawsuit.
Disclaimer: This story is generated from RSS Feed and has not been created or edited by Waba News. Publisher: CNBC